戻る Agenda
DISC and RISK: How DISC Profile in Clinical Trial Teams Impact Implementation of Risk-Based Approaches
Session Chair(s)
Dawn Auerbach, MPA
Executive Director, Client Development
The Avoca Group, United States
An interactive workshop that instructs attendees on how to best implement and operationalize risk-based approaches to clinical operations and quality management by recognizing what their DISC ( D- Dominance, I – Influence, S – Steadiness and C – Compliant) profile makes them most apt to do and how each of these personality types plays a key role in the design, development, and implementation of a new idea and how each personality type has a varied risk tolerance.
Learning Objective : Identify your DISC personality type; Identify strategies for analyzing the situation from an alternative viewpoint/DISC type to facilitate change management and adoption; Discuss how personality type variations in clinical trial execution impact risk-based approach implementation and may be leveraged for success.
Speaker(s)
Facilitator
William E Bennett, MS
CEO Empowerment LLC, United States
Principal
Facilitator
Jay A Turpen
Diligent Pharma LLC, United States
Head, Quality Assurance